You are viewing: Japan Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The Japan Biopreservation Market was valued at $115.4 Million in 2024 and projected to reach to $189.4 Million by 2029, representing a compound annual growth rate of CAGR 10.4%. Japan's biopreservation market is positioned for sustained growth through 2029, driven by demographic shifts and technological advancement.

Japan Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Biopreservation Market Trends and Insights

  • Japan is advancing its biopreservation capabilities driven by increasing demand for cell and tissue preservation in regenerative medicine, pharmaceutical research, and clinical applications.
  • Japan's aging population and strong healthcare infrastructure are accelerating adoption of biopreservation technologies across hospitals, research institutions, and biotech companies. The Japanese biopreservation sector benefits from significant investment in life sciences innovation and regulatory support for advanced medical therapies.
  • Japan's commitment to precision medicine and stem cell research is propelling market expansion through 2029.
  • Key applications in Japan include cryopreservation of reproductive cells, organ preservation, and biobanking services, supported by Japan's sophisticated cold chain logistics and quality control standards..

Key Market Statistics

  • CAGR (2024-2029) CAGR 10.4%
  • Market Size, 2024 ~USD 115.4 Million
  • Forecast, 2029 ~USD 189.4 Million
  • Country Japan

Japan Biopreservation Market Overview

Market Valuation & Growth :

Japan's biopreservation market is valued at $115.4 million in 2024, with a robust CAGR of 10.4% projected through 2029, reaching $189.4 million. This growth rate outpaces the global average of 9.8%, indicating Japan's accelerating adoption of biopreservation technologies.

Aging Population Driver :

Japan's rapidly aging demographic is a key catalyst for biopreservation demand. The need for advanced cell and tissue preservation solutions in geriatric care, regenerative medicine, and age-related disease treatment is driving market expansion across clinical and research sectors.

Regenerative Medicine Leadership :

Japan is establishing itself as a regional leader in regenerative medicine applications. Strong government support, advanced research institutions, and clinical adoption of stem cell therapies are creating substantial demand for sophisticated biopreservation infrastructure and cryopreservation solutions.

Healthcare Infrastructure Strength :

Japan's world-class healthcare system, high R&D investment, and regulatory framework supporting advanced medical technologies provide an ideal environment for biopreservation market growth. Pharmaceutical companies and research institutions are increasingly investing in preservation capabilities.

Japan Biopreservation Market Dynamics

  • The aging population creates urgent demand for cell and tissue preservation in regenerative medicine and therapeutic applications.
  • Japan's strong healthcare infrastructure, coupled with significant government investment in life sciences research, supports market expansion across pharmaceutical, clinical, and research sectors. The market will benefit from increasing adoption of cryopreservation technologies, growing clinical applications in regenerative medicine, and expanding partnerships between Japanese research institutions and global biotech companies.
  • Regulatory support for advanced medical technologies and Japan's leadership in stem cell research will continue to accelerate biopreservation adoption, positioning the country as a key growth market in the Asia-Pacific region..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Japan's biopreservation market will grow from $115.4M (2024) to $189.4M (2029) at a 10.4% CAGR.
    • Japan's aging demographics and regenerative medicine focus are primary growth catalysts for biopreservation adoption.
    • Japan leads in cryopreservation technology and biobanking infrastructure within the Asia Pacific region.
    • Japan's regulatory environment and precision medicine initiatives support sustained market expansion through 2029.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    Japan Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    JAPAN: BIOPRESERVATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BIOBANKS61.268.576.485.794.9105.2118.4132.411.6
    GENE BANKS424752576370778510.3
    HOSPITALS60677481899910912110.3
    OTHER END USERS252830333740444910.3
    TOTAL188.2210.5232.4256.7283.9314.2348.4387.410.8

    Target Audience

    • Pharmaceutical & Biotech Companies : Japanese and international pharma firms need Japan-specific biopreservation market data to evaluate R&D investments, clinical trial infrastructure, and market entry strategies in this high-growth segment.
    • Healthcare Providers & Hospitals : Japanese hospitals and clinical institutions require market insights to justify biopreservation technology investments, understand adoption trends, and plan regenerative medicine program expansion.
    • Research Institutions & Universities : Academic and research organizations in Japan need market data to secure funding, demonstrate commercial viability of biopreservation research, and identify collaboration opportunities with industry partners.
    • Medical Device & Equipment Manufacturers : Equipment suppliers targeting Japan's biopreservation sector need localized market intelligence to develop products, establish distribution channels, and understand competitive dynamics in this growing market.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Japanese life sciences need detailed market analysis, growth projections, and sector dynamics to identify promising biopreservation companies and investment opportunities.

    Reasons to Buy this Report

    • Japan-Specific Market Sizing : Obtain precise valuation data for Japan's biopreservation market with verified 2024 baseline ($115.4M) and 2029 forecasts ($189.4M). Make informed investment and expansion decisions based on Japan-specific market intelligence rather than global averages.
    • Demographic-Driven Growth Insights : Understand how Japan's aging population directly impacts biopreservation demand. Gain actionable insights into clinical applications, regenerative medicine adoption rates, and market opportunities specific to Japan's unique demographic and healthcare landscape.
    • Competitive Positioning in Asia-Pacific : Benchmark Japan's 10.4% CAGR against global 9.8% growth to identify competitive advantages. Develop market entry or expansion strategies tailored to Japan's regulatory environment, research institutions, and pharmaceutical sector dynamics.
    • Sector-Specific Application Data : Access detailed analysis of biopreservation applications across Japanese pharmaceutical research, clinical regenerative medicine, and tissue banking sectors. Identify high-growth subsegments and emerging opportunities within Japan's healthcare ecosystem.
    • Strategic Partnership Opportunities : Leverage Japan-specific market intelligence to identify collaboration opportunities with research institutions, healthcare providers, and biotech companies. Understand the regulatory pathway and investment climate for biopreservation technologies in Japan.

    Frequently asked questions

    What is the current size of Japan's biopreservation market?

    Japan's biopreservation market was valued at $115.4 million in 2024 and is expected to reach $189.4 million by 2029.

    What is the growth rate of biopreservation in Japan?

    Japan's biopreservation market is growing at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2029.

    What are the main applications of biopreservation in Japan?

    Key applications in Japan include cryopreservation of reproductive cells, organ preservation, biobanking services, and stem cell research for regenerative medicine.

    What factors are driving biopreservation market growth in Japan?

    Japan's aging population, strong healthcare infrastructure, investment in precision medicine, and regulatory support for advanced therapies are primary growth drivers.

    How does Japan's biopreservation market compare regionally?

    Japan is a leading market in the Asia Pacific region for biopreservation technology, supported by advanced infrastructure and significant life sciences investment.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status